Cargando…

A joinpoint and age–period–cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016

Investigating secular trends of ocular cancer registration in Iran. After acquiring Iranian national population-based cancer registry data, trends of age-standardised incidence rates (ASIR) of ocular cancers and annual percent changes (APC) between 2004 and 2016 were analysed in age groups, gender,...

Descripción completa

Detalles Bibliográficos
Autores principales: Abolhosseini, Mohammad, Khorrami, Zahra, Safi, Sare, Akbari, Mohammad Esmaeil, Moshtaghion, Seyed Mohamadmehdi, Mohammadi, Seyed Farzad, Kanavi, Mozhgan Rezaei, Karimi, Saeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852578/
https://www.ncbi.nlm.nih.gov/pubmed/36658192
http://dx.doi.org/10.1038/s41598-022-26349-x
_version_ 1784872676641210368
author Abolhosseini, Mohammad
Khorrami, Zahra
Safi, Sare
Akbari, Mohammad Esmaeil
Moshtaghion, Seyed Mohamadmehdi
Mohammadi, Seyed Farzad
Kanavi, Mozhgan Rezaei
Karimi, Saeed
author_facet Abolhosseini, Mohammad
Khorrami, Zahra
Safi, Sare
Akbari, Mohammad Esmaeil
Moshtaghion, Seyed Mohamadmehdi
Mohammadi, Seyed Farzad
Kanavi, Mozhgan Rezaei
Karimi, Saeed
author_sort Abolhosseini, Mohammad
collection PubMed
description Investigating secular trends of ocular cancer registration in Iran. After acquiring Iranian national population-based cancer registry data, trends of age-standardised incidence rates (ASIR) of ocular cancers and annual percent changes (APC) between 2004 and 2016 were analysed in age groups, gender, topography and morphology types with joinpoint regression analysis. Age, period, and cohort effects on incidence rates were estimated by age–period–cohort model. Geographic distribution of ASIR was assessed using GIS. Overall ASIR of ocular cancers was 16.04/100,000 (95% CI 15.77–16.32). Joinpoint regression analysis showed a significant increase of ASIR between 2004 and 2009 for males (APC = 5.5, 95% CI  0.9–10.2), ages over 50 years (APC = 5.2, 1.2–9.4), skin/canthus/adnexal cancers (APC = 4.2, 0.8–7.7), and carcinomas/adenocarcinomas (APC = 4.3, 0.6–8.1); however, between 2009 and 2016 a declining trend was observed in all investigated variables. ASIR of retinoblastoma was significantly increased (averaged APC = 20.7, 9–33.7) between 2004 and 2016. age–period–cohort analyses showed that incidence rates of ocular cancers significantly increased with aging, time periods, and birth cohort effects (p < 0.001). ASIR varied from 6.7/100,000 to 21.7/100,000 in Iran. Excepting retinoblastoma, all ocular cancer incidence trends were downward over a 13-year period; however, it was increasing between 2004 and 2009 cancer. ASIR was significant aging in Iran.
format Online
Article
Text
id pubmed-9852578
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-98525782023-01-21 A joinpoint and age–period–cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016 Abolhosseini, Mohammad Khorrami, Zahra Safi, Sare Akbari, Mohammad Esmaeil Moshtaghion, Seyed Mohamadmehdi Mohammadi, Seyed Farzad Kanavi, Mozhgan Rezaei Karimi, Saeed Sci Rep Article Investigating secular trends of ocular cancer registration in Iran. After acquiring Iranian national population-based cancer registry data, trends of age-standardised incidence rates (ASIR) of ocular cancers and annual percent changes (APC) between 2004 and 2016 were analysed in age groups, gender, topography and morphology types with joinpoint regression analysis. Age, period, and cohort effects on incidence rates were estimated by age–period–cohort model. Geographic distribution of ASIR was assessed using GIS. Overall ASIR of ocular cancers was 16.04/100,000 (95% CI 15.77–16.32). Joinpoint regression analysis showed a significant increase of ASIR between 2004 and 2009 for males (APC = 5.5, 95% CI  0.9–10.2), ages over 50 years (APC = 5.2, 1.2–9.4), skin/canthus/adnexal cancers (APC = 4.2, 0.8–7.7), and carcinomas/adenocarcinomas (APC = 4.3, 0.6–8.1); however, between 2009 and 2016 a declining trend was observed in all investigated variables. ASIR of retinoblastoma was significantly increased (averaged APC = 20.7, 9–33.7) between 2004 and 2016. age–period–cohort analyses showed that incidence rates of ocular cancers significantly increased with aging, time periods, and birth cohort effects (p < 0.001). ASIR varied from 6.7/100,000 to 21.7/100,000 in Iran. Excepting retinoblastoma, all ocular cancer incidence trends were downward over a 13-year period; however, it was increasing between 2004 and 2009 cancer. ASIR was significant aging in Iran. Nature Publishing Group UK 2023-01-19 /pmc/articles/PMC9852578/ /pubmed/36658192 http://dx.doi.org/10.1038/s41598-022-26349-x Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Abolhosseini, Mohammad
Khorrami, Zahra
Safi, Sare
Akbari, Mohammad Esmaeil
Moshtaghion, Seyed Mohamadmehdi
Mohammadi, Seyed Farzad
Kanavi, Mozhgan Rezaei
Karimi, Saeed
A joinpoint and age–period–cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016
title A joinpoint and age–period–cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016
title_full A joinpoint and age–period–cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016
title_fullStr A joinpoint and age–period–cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016
title_full_unstemmed A joinpoint and age–period–cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016
title_short A joinpoint and age–period–cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016
title_sort joinpoint and age–period–cohort analysis of ocular cancer secular trends in iran from 2004 to 2016
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852578/
https://www.ncbi.nlm.nih.gov/pubmed/36658192
http://dx.doi.org/10.1038/s41598-022-26349-x
work_keys_str_mv AT abolhosseinimohammad ajoinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016
AT khorramizahra ajoinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016
AT safisare ajoinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016
AT akbarimohammadesmaeil ajoinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016
AT moshtaghionseyedmohamadmehdi ajoinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016
AT mohammadiseyedfarzad ajoinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016
AT kanavimozhganrezaei ajoinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016
AT karimisaeed ajoinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016
AT abolhosseinimohammad joinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016
AT khorramizahra joinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016
AT safisare joinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016
AT akbarimohammadesmaeil joinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016
AT moshtaghionseyedmohamadmehdi joinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016
AT mohammadiseyedfarzad joinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016
AT kanavimozhganrezaei joinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016
AT karimisaeed joinpointandageperiodcohortanalysisofocularcancerseculartrendsiniranfrom2004to2016